Wereport a patient with KL-6-producing invasive thymoma.A 58-year-old man was admitted complaining of dyspnea and fatigability. Computedtomography of the chest revealed interstitial pneumoniaand an anterior mediastinal tumor. The tumor was surgically extirpated and diagnosed as invasive thymoma. Serum KL-6 levels later increased further and another tumor was found in the liver. That liver tumor was resected and histologically diagnosed as a metastasis of thymoma.Following resection, the serum KL-6 level decreased. Tumor cells of both primary and metastatic lesions exhibited positive reactivity to immunohistochemical staining for KL-6. A review of this case is presented. (Internal Medicine 41: 979-982, 2002) 
Introduction
Thymoma is the most commonprimary neoplasm of the anterior mediastinum, and can generally be cured by complete surgical extirpation. However, about one-third of patients demonstrate extensive growth, and lymph node or hematogenous metastasis, which may occur in both encapsulated and invasive types (1) . The sites of hematogenousmetastasis include lung, liver, bone, and others (2) . In this case, both primary and metastatic lesions of thymoma were surgically extirpated and exhibited positive reactivity to immunohistochemical staining for KL-6.
KL-6 is a mucin-like high-molecular-weight glycoprotein that generally indicates the degree of fibrotic and destructive changes of lung structure (3) . However, it is reported that the increased expression of MUC1 mucin, into which KL-6is classified, is associated with metastatic potential and poor prognoses of malignant tumors (4-7). Whenserum levels of KL-6 increase, the existence of malignant tumors such as invasive thymomamay need to be considered even if the patient appears to be suffering from interstitial pneumonia.
Case Report
A 58-year-old man, who had been clinically diagnosed with interstitial pneumonia in June 1998 at another hospital, was admitted to our hospital in July 1998, complaining of dyspnea and fatigability. His medical history showed gout, thrombophlebitis, hypertension and colon cancer (left hemicolectomy had been performed in 1 995). Physical examination revealed crepitant rales in bilateral lower lung fields. Radiography of the chest revealed a reticular shadow, predominantly in bilateral lower lung fields and an anterior mediastinal mass (Fig. 1) . Computed tomographyof the chest also revealed a reticular shadow in bilateral lower lobes of the lung and an anterior mediastinal mass (Fig. 2 ). Transbronchial lung biopsy revealed possible non-specific interstitial pneumonia. Administration of oral glucocorticosteroid (initiated at 40 mg/day then tapered to 20 mg/day) resulted in improvement of symptoms. Twomonths later (September 1998), computed tomography of the chest was again performedand the same anterior mediastinal masswas revealed. Theabsence of changein the mass over the two-month period suggested a diagnosis of noninvasive thymoma.However, because the tumor had invaded the right lung and pericardium, total thymectomy and partial resection of the right middle lobe of the lung with pleura and pericardium was performed in October 1998. Histopathology showed the polygonal epithelial cells of the tumor disposing in solid sheets and invading the peripheral adipose tissue through the capsule. For these reasons, this tumor was diagnosed as invasive thymoma (epithelial type). in 1995) was initially suspected. Partial hepatic resection was performed in May2000. However, the resected lesion was histologically diagnosed as metastatic thymoma. In October 2000, computed tomography of the abdomen revealed multiple liver metastases. Radiotherapy and chemotherapy were considered inappropriate options because of the patient's underlying interstitial pneumonia, and methods of best supportive care were selected.
Immunohistochemistry
Serum levels of KL-6 increased to 2,000-3,000 U/ml (2,360 U/ml in July 1999, 3,060 U/ml in October 1999, 1,920 U/ml in December 1999; normal range <500 U/ml) without exacerbation of interstitial pneumonia before the liver tumor was identified. Following resection of the tumor, serum levels of KL-6 decreased to 939 U/ml. A KL-6-producing tumor was therefore suspected and immunohistochemical staining was performed. As both primary and metastatic lesions exhibited positive reactivity to anti-KL-6 staining (Fig. 4) , this case was diagnosed as KL-6-producing invasive thymoma with liver metastasis.
D iscussion
Thymomais the most commonprimary neoplasm of the anterior mediastinum. Patients with benign thymomas, which show no histological invasion of the capsule, can be cured by complete surgical extirpation. However,invasive thymoma exhibits extensive invasion through the capsule, and frequent lymph node or hematogenous metastases (1, 2) . About onethird of patients demonstrate extensive growth, and lymph node or hematogenous metastasis (1). Okumura et al (8) reported that in 273 patients with thymomawho had experienced surgical resection of tumors, 124 were diagnosed as non-invasive thymomawhich was defined as stage I by the classification system ofMasaokaet al (9) . In this case, the tumor cells of the primary lesion invaded the surrounding adipose tissue through the capsule, providing support for diagnosis of the tumor as invasive thymoma. One year after extirpation of the primary lesion, elevated serum levels of KL-6 (up to 3,060 U/ml in October 1999) decreased (to 939 U/ml in April 2000) following resection of the metastatic lesion. The relation between the primary lesion and serum levels of KL-6was uncertain because we did not examine the KL-6 level before and immediately after resection of the primary lesion. As the possibilities of not only exacerbation of the interstitial pneumonia but also a KL-6-producing tumor were suspected, we performed immunohistochemical staining. Since the primary and metastatic lesions both exhibited positive reactivity to anti-KL-6 staining, we diagnosed the tumor as KL-6-producing invasive thymoma. Whenfurther metastatic lesions were identified in October 2000, serum levels of KL-6 did not increase. This may be due to the heterogeneity of the tumor lineage, as some cells in the initial anti-KL-6 staining did not exhibit positive reactivity. KL-6, a mucin-like high molecular weight glycoprotein, is classified as "Cluster 9 (MUC1)" of lung tumor and differentiation antigens, according to the findings of immunohistochemical and flow cytometry studies (10) . Since KL-6 is predominantly expressed on type 2 pneumocytes and respiratory bronchiolar epithelial cells, its serum levels are used as an indicator of disease activity in interstitial lung diseases (3). Actually, the area of interstitial pneumonia from the lung of this patient resected at the thymectomyexhibited positive reactivity to immunohistochemical staining for KL-6 (Fig. 5) . But the relation between the activities of thymomaand interstitial pneumonia is uncertain, because the thymomashowed obvious progression without exacerbation of the interstitial pneumonia. HumanMUC1 mucin is the major componentof the ductal cell surface of normal glandular cells (ll). However, MUC1
overexpression inhibits cell-to-extracellular matrix or cell-tocell adhesion (12, 13) , and the increased expression ofMUC1 mucin is associated with poor prognoses of malignant tumors (4) (5) (6) (7) . Although it has been reported that the serum levels of KL-6 are elevated in patients with malignancies such as lung adenocarcinoma (14), whether or not the normal thymus and/ or thymomacells express KL-6 is still uncertain. In this patient, because not all tumor cells express KL-6, we suppose the possibility that the non-KL-6-expressing cells of the thymus were transformed into thymomacells and some of those cells further acquired the character of metastasis accompaniedwith an increased expression of KL-6.
In conclusion, we reported the case of KL-6-producing invasive thymoma. While this patient had been diagnosed as in- terstitial pneumonia, the invasive thymomawas thought to be a contributing factor to the increased serum level of KL-6. This occurrence, the invasive thymomaalong with the increased level of KL-6, suggests the possibility that KL-6 could be used as an indicator of the invasiveness of thymoma. So, when serum levels of KL-6increase, the existence of malignanttumors such as invasive thymomamay need to be considered even if the patient appears to be suffering from interstitial pneumonia.
